CRVS Corvus Pharmaceuticals, Inc. - Common Stock
$11,93
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مايو 7, 2026
نطاق 52 أسبوعًا
$3–$27
36% of range
تقييم المحللين
BUY
13 analysts
السعر المستهدف
$33
+179% upside
P/E (TTM)
-14.5
ROE
-21.6%
هامش صافي الربح
—
CRVS لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$11.93
القيمة السوقية
$575M
P/E (TTM)
-14.5
ربح السهم (آخر 12 شهرًا)
$-0.53
الإيرادات (آخر 12 شهرًا)
—
عائد التوزيعات
—
ROE
-21.6%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$3 – $27
CRVS مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
—
ربح السهم
$-0.53
2019-12-31
→
2025-12-31
التدفق النقدي الحر
$-33M
2018-12-31
→
2025-12-31
الهوامش
—
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
CRVS
متوسط الأقران
P/E (TTM)
-14.5
86.6
P/B (السعر / القيمة الدفترية)
9.4
4.0
Price / FCF (السعر / التدفق النقدي الحر)
-17.4
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
CRVS
متوسط الأقران
ROA (العائد على الأصول)
-21.8%
-38.7%
ROE
-21.6%
-46.2%
ROIC
-70.2%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
CRVS
متوسط الأقران
Current Ratio (النسبة الحالية)
6.2
9.5
Quick Ratio (النسبة السريعة)
0.5
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
CRVS
متوسط الأقران
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
CRVS
متوسط الأقران
CRVS توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
13 محللين
- شراء قوي 4 30,8%
- شراء 8 61,5%
- احتفاظ 1 7,7%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
6 محللين · 2026-05-17
الوسيط
$31.50
المتوسط
$33.33
← أقل من جميع الأهداف
$11.93
منخفض
$27.00
مرتفع
$42.00
السعر المستهدف الوسيط
$31.50
+164,0%
السعر المستهدف المتوسط
$33.33
+179,4%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.07%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-0.15 | $-0.15 | -0.00% |
| 31 ديسمبر، 2025 | $-0.15 | $-0.13 | -0.02% |
| 30 سبتمبر، 2025 | $-0.12 | $-0.14 | 0.02% |
| 30 يونيو، 2025 | $-0.10 | $-0.14 | 0.04% |
| 31 مارس، 2025 | $0.21 | $-0.12 | 0.33% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| PURR | — | — | — | — | — | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| AKTS | — | — | — | — | — | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
الميزانية العمومية 23
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $318.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
التدفق النقدي 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
الربحية 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
السيولة والملاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
التقييم (آخر 12 شهرًا) 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
قائمة الدخل 13
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | $5M | |
| SG&A Expense | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | $7M | |
| Operating Income | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M | |
| Other Non-op | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | · | |
| Pretax Income | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-5M | $-6M | · | · | · | |
| Income Tax | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-7M | $-6M | $-7M | $-8M | $-15M | $-8M | $-8M | |
| EPS (Basic) | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| EPS (Diluted) | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | |
| Shares (Basic) | 89,996,728 | -153,772,367 | 82,836,369 | 77,774,344 | 72,126,496 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 89,996,728 | -156,020,542 | 82,836,369 | 77,774,344 | 75,152,514 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | 46,553,511 | |
| EBITDA | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | · | $-6M | $-6M | $-7M | $-12M | $-7M | $-7M |
الميزانية العمومية 22
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | · | $20M | $8M | $10M | $25M | $28M | $31M | |
| Receivables | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | · | $11.0K | · | · | · | · | · | |
| Prepaid Expense | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | · | $915.0K | $893.0K | $655.0K | $1M | $2M | $1M | |
| Other Current Assets | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | · | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | $130.0K | |
| Current Assets | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | · | $33M | $38M | $36M | $51M | $59M | $64M | |
| PP&E (Net) | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | · | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | $364.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $4M | $4M | |
| Other Non-current Assets | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | · | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | $236.0K | |
| Total Assets | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | $101M | |
| Accounts Payable | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | · | $1M | $2M | $1M | $4M | $3M | $2M | |
| Accrued Liabilities | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | · | $7M | $8M | $8M | $14M | $10M | $9M | |
| Capital Leases | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | $2M | |
| Total Liabilities | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | · | $8M | $9M | $9M | $16M | $12M | $12M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | · | $-328M | $-322M | $-316M | $-298M | $-283M | $-275M | |
| AOCI | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | · | $-1M | $-1M | $-434.0K | $-1M | $339.0K | $2M | |
| Stockholders' Equity | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $39M | $44M | $49M | $49M | $65M | $80M | $90M | |
| Liabilities + Equity | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | $101M | |
| Shares Outstanding | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | · | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 | 46,553,511 |
التدفق النقدي 11
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $28.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | $87.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $572.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | $739.0K | |
| Other Non-cash | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | · | $-787.0K | · | · | $1M | |
| Operating Cash Flow | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | $-6M | |
| CapEx | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $0 | $34.0K | $265.0K | · | · | |
| Investing Cash Flow | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $-2M | $18M | $-4M | $5M | $3M | $3M | $-26M | |
| Stock Issued | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $0 | $335.0K | $8M | $4.0K | · | · | · | |
| Net Change in Cash | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $-7M | $12M | $-2M | $-4M | $-4M | $-3M | $-32M | |
| Free Cash Flow | $-10M | · | · | · | $-8M | · | · | · | · | · | · | · | $-8M | · | · | · |
الربحية 3
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | · | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | -7.9% | |
| ROE | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | · | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | -9.0% | |
| ROIC | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · | · |
السيولة والملاءة 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | · | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | 6.9 | |
| Quick Ratio | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | · | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 | 3.4 |
التقييم (آخر 12 شهرًا) 8
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-17M | · | $-43M | $-37M | $-35M | · | $-56M | $-22M | $-26M | · | $-35M | $-38M | $-39M | $-42M | $-39M | $-42M | |
| Market Cap | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | · | $72M | $112M | $42M | $38M | $46M | $76M | |
| P/E | -29.3 | · | -7.8 | -4.4 | -3.5 | · | -5.8 | -4.0 | -3.2 | · | -1.9 | -2.8 | -1.1 | -0.9 | -1.2 | -1.8 | |
| P/B | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Tangible Book | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | 0.9 | |
| P / Cash Flow | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | · | -5.2 | · | · | -11.9 | |
| P / FCF | -117.6 | · | · | · | -26.1 | · | · | · | · | · | · | · | -5.2 | · | · | · | |
| Earnings Yield | -3.4% | · | -12.9% | -22.5% | -28.9% | · | -17.2% | -24.7% | -30.9% | · | -51.4% | -35.4% | -93.4% | -107.5% | -80.8% | -54.9% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| صافي الدخل | $-15M | $-62M | $-27M | $-41M | $-43M |
| EPS المخفف | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| النسبة السريعة | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-33M | — | $-24M | $-27M | $-37M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.